Pharmacotherapy -- first-line maintenance therapy
- Pharmacotherapy -- treatment of intermittent asthma with ICSs. // CMAJ: Canadian Medical Association Journal;9/13/2005 Supplement, Vol. 173, pS33
The article discusses the efficacy of using inhaled corticosteroids (ICSs) in the treatment of intermittent asthma in infants and children. It mentions several clinical studies which reveal the effectiveness of an intermittent therapy with ICSs. It has been noted that the results of the studies...
- In patients with asthma that is not well controlled with inhaled steroids, does salmeterol (Serevent) or montelukast (Singulair) offer better symptom relief? Cash, Richard; Blonski, Joseph // Journal of Family Practice;Sep2001, Vol. 50 Issue 9, p802
The article discusses research being done on the evaluation of salmeterol and montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids. It references a study by A. M. Wilson et al published in the 2001 issue of "Chest." It reveals that many asthmatics do not have...
- Assessment of a revolving drug fund for essential asthma medicines in Benin. Agodokpessi, Gildas; Aït-Khaled, Nadia; Gninafon, Martin; Tawo, Leon; Bekou, Wilfried; Perrin, Christophe; Bissell, Karen; Billo, Nils; Enarson, Donald A.; Chen-Yuan Chiang // Journal of Pharmaceutical Policy & Practice;Apr2015, Vol. 8, p1
Objectives: Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated the operation of the RDF and assessed whether there was interruption of supply of asthma medicine from 2008 to 2013. Methods: We reviewed the process in establishing the RDF. We...
- Once a day asthma treatment. // Pediatrics for Parents;1999, Vol. 18 Issue 9, p7
Focuses on article about the corticosteroid treatment of childhood asthma, published in the October 15, 1998 issue of the `Doctor's Guide' periodical. Use of Pulmicort as a once-a-day treatment option for asthma; Mechanism of action of corticosteroids.
- Once-daily oral leukotriene blocker is cleared for the treatment of asthma. // Modern Medicine;Apr98, Vol. 66 Issue 4, p58
Introduces Montelukast sodium, an oral leukotriene blocker for the treatment of asthma in patients aged six years and older. Mechanism of action of the drug; Side effects.
- Ten-year prescription trends of asthma medications in the management of childhood wheeze. Soh, Jian Yi; Ng, Beatrice; Tan, Zeying; Xu, Shuhui; Hing, Wee Chuan; Wu, Tuck Seng; Chan, Yiong Huak; Lee, Bee Wah // Allergy & Asthma Proceedings;Jan/Feb2014, Vol. 35 Issue 1, p1
Asthma is the most common chronic disorder of childhood. The aim of this study was to assess prescription trends of asthma medications to provide a measure to evaluate treatment practices and compliance with established international practice guidelines. A retrospective study of data obtained...
- Adverse drug reactions associated with asthma medications in children: systematic review of clinical trials. Aagaard, Lise; Hansen, Ebba // International Journal of Clinical Pharmacy;Apr2014, Vol. 36 Issue 2, p243
Background Respiratory medications are frequently prescribed for use in children. Several studies have reported information on the safety of asthma medications in clinical studies in adults, but information about safety in children is scarce. Objective To review published clinical trials on the...
- Survey shows that many asthma patients are misinformed about their medications. // Modern Medicine;Jun98, Vol. 66 Issue 6, p14
Presents an abstract of the article `Perception of the Role and Potential Side Effects of Inhaled Corticosteroids Among Asthmatic Patients,' from the journal `Chest' dated March 1998.
- Summary of recommendations from the Canadian Asthma Consensus Guidelines, 2003. Becker, Allan; Lemièbre, Catherine; Bérubé, Denis; Boulet, Louis-Philippe; Ducharme, Francine M.; FitzGerald, Mark; Kovesi, Thomas // CMAJ: Canadian Medical Association Journal;9/13/2005 Supplement, Vol. 173, pS3
The article presents the recommendations from the Canadian Asthma Consensus Guidelines for prevention, assessment and management of asthma in children and adults. Optimal management of this disease requires sufficient evaluation of the patient and his environment. In preventing, intervention...